Highstreet Asset Management’s Jazz Pharmaceuticals JAZZ Stock Holding History

Highstreet Asset Management’s Portfolio JAZZ Stock Details JAZZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	$401K	Sell	2,689 -7,172	-73%	-$976K	0.02%	263
2019 Q3	$1.26M	Sell	9,861 -2,837	-22%	-$380K	0.06%	116
2019 Q2	$1.81M	Buy	12,698 +2,285	+22%	+$307K	0.09%	96
2019 Q1	$1.49M	Buy	+10,413	New	+$1.36M	0.09%	104
2018 Q3	–	Sell	-5,569	Closed	-$960K	–	384
2018 Q2	$960K	Sell	5,569 -589	-10%	-$96.3K	0.06%	141
2018 Q1	$930K	Buy	6,158 +2,670	+77%	+$392K	0.06%	135
2017 Q4	$470K	Buy	3,488 +581	+20%	+$80.6K	0.03%	187
2017 Q3	$425K	Buy	+2,907	New	+$440K	0.04%	181

Other funds holding JAZZ

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return

Highstreet Asset Management's JAZZ Position: Q4 2019 in Review

Highstreet Asset Management reduced its Jazz Pharmaceuticals (JAZZ) stake by 73% in Q4 2019, selling an estimated $976K and leaving 2,689 shares worth $401K. The position accounts for 0.02% of the portfolio, ranked #263.

Highstreet Asset Management first reported a position in JAZZ in Q3 2017 and has held it in 8 quarters since. The position peaked at $1.81M in Q2 2019. 446 funds tracked by Wall St. Rank hold JAZZ as of Q4 2019.

Highstreet Asset Management held 2,689 shares of Jazz Pharmaceuticals worth $401K as of Q4 2019.
Highstreet Asset Management sold 7,172 Jazz Pharmaceuticals shares in Q4 2019, an estimated $976K.
Jazz Pharmaceuticals made up 0.02% of Highstreet Asset Management's portfolio in Q4 2019, its #263 holding.
Highstreet Asset Management first reported a position in Jazz Pharmaceuticals in Q3 2017 and has held it in 8 quarters since.
Highstreet Asset Management's Jazz Pharmaceuticals position peaked at $1.81M in Q2 2019.
446 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q4 2019.

Based on Highstreet Asset Management's 13F filing for Q4 2019, filed 12 Feb 2020.